INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE TOP 21
13

Vegetable · Edible fungi (cooked as a vegetable)

Mushrooms

Technically fungi, and consistently linked with lower cancer risk.

EVIDENCE TYPE

Population studies

Large observational studies tracked people who eat this specific food; they show associations, not proof of cause.

NUTRIENT DENSITY

Not part of the published powerhouse score, or below its cutoff. That score counts vitamins and minerals, not plant compounds.

Why it earns a place

Mushrooms are not plants at all, but they shop, cook and eat like vegetables. Their savory depth also makes them one of the most useful ingredients in oil-free cooking.

What the research shows

  1. 1

    A meta-analysis of 17 observational studies found people eating the most mushrooms had 34% lower risk of any cancer (RR 0.66) and 35% lower risk of breast cancer.

    Ba DM, Ssentongo P, Beelman RB, Muscat J, et al. Advances in nutrition (Bethesda, Md.), 2021. PMID 33724299 · DOI

  2. 2

    In a pooled analysis of 11 studies (3,900 cases), higher mushroom consumption was associated with 18% lower gastric cancer risk (RR 0.82).

    Ba DM, Ssentongo P, Pelucchi C, Negri E, et al. European journal of cancer prevention, 2023. PMID 36912187 · DOI

  3. 3

    Among 152,828 Korean adults followed for 11.6 years, eating mushrooms one to three times a week was associated with lower all-cause mortality in both men and women than eating none.

    Jung H, Shin J, Lim K, Shin S. Food & function, 2023. PMID 37682230 · DOI

What it doesn’t show

  • Eleven of the 17 studies in the cancer meta-analysis were case-control designs, prone to recall and selection bias, and only breast cancer showed a significant site-specific link.

    Ba DM, Ssentongo P, Beelman RB, Muscat J, et al. Advances in nutrition (Bethesda, Md.), 2021. PMID 33724299 · DOI

  • Buy cultivated mushrooms from a grocer; never eat wild mushrooms unless they are identified by an expert.

FROM THE STUDY LIBRARY

More studies on mushrooms

20 peer-reviewed studies, each summarized from its published abstract. Strongest study types first.

2019 / Systematic review of clinical studies

Clinical studies link mushroom-derived lentinan to benefits during conventional cancer therapy.

A systematic review evaluated 135 clinical studies from China comprising 9,474 cancer treatment cases involving the shiitake polysaccharide lentinan. Most cases involved lung (3,469), gastric (3,039), or colorectal (1,646) malignancies. Across evaluated reports, lentinan use was linked to better quality of life and greater efficacy of concurrent chemotherapy or radiation treatment.

Zhang M, Zhang Y, Zhang L, et al. Prog Mol Biol Transl Sci, 2019. PMID 31030752

2012 / Meta-analysis of randomized controlled trials

Reishi mushroom as an adjunct to cancer therapy showed potential immune and response benefits

A meta-analysis of five randomized trials examined Ganoderma lucidum in cancer care. Combining the mushroom with chemotherapy or radiotherapy increased the likelihood of a positive response compared to conventional therapy alone (RR 1.50, 95% CI 0.90 to 2.51). Furthermore, supplementation raised CD3, CD4, and CD8 percentages by 3.91%, 3.05%, and 2.02%, while quality of life was relatively improved in four studies.

Jin X, Ruiz Beguerie J, Sze DM, et al. Cochrane Database Syst Rev, 2012. PMID 22696372

2020 / Pooled prospective cohort study

Frequent mushroom intake was associated with a decreased risk of incident prostate cancer in Japanese men.

Researchers analyzed pooled data from 36,499 Japanese men followed for a median of 13.2 years (574,397 person-years) to examine mushroom consumption and prostate cancer risk. During follow-up, 1,204 incident prostate cancer cases (3.3%) occurred. Compared to consuming mushrooms <1 time/week, consumption 1-2 times/week was associated with an HR of 0.92 (95% CI: 0.81, 1.05) and ≥3 times/week with an HR of 0.83 (95% CI: 0.70, 0.98; p-trend = 0.023). This inverse relationship was particularly apparent in men aged ≥50 years and did not differ by clinical cancer stage or intake of vegetables, fruit, meat, and dairy products.

Shows an association, not proof of cause and effect.

Zhang S, Sugawara Y, Chen S, et al. Int J Cancer, 2020. PMID 31486077

2020 / Case report

A patient developed shiitake mushroom flagellate dermatitis three days after eating shiitake mushrooms in Tokyo.

This report details a patient who developed a striking linear flagellate dermatitis without urticaria three days after returning from Tokyo, where he consumed shiitake mushrooms (Lentinula edodes). The rash resolved after two weeks following treatment with topical corticosteroids and antihistamines for symptomatic relief. Shiitake dermatitis is considered to be a toxic or hypersensitivity reaction to lentinan, a heat-inactivated polysaccharide present in the mushroom's cell walls.

Shows an association, not proof of cause and effect.

Heer RS, Patel NB, Mandal AKJ, et al. Am J Emerg Med, 2020. PMID 31864870

See all 20 studies →

Educational content, not medical advice. These studies describe associations or short-term risk markers; they do not show that any single food treats or prevents disease.